Caren L. Freel Meyers

Also affiliated with Johns Hopkins Medicine, Therapeutics Clinical Research, Io Therapeutics (United States)

Biochemistry, Genetics and Molecular BiologyMaterials ScienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Investigating inhibitors of 1-deoxy- d -xylulose 5-phosphate synthase in a mouse model of UTI”.

Investigating inhibitors of 1-deoxy- d -xylulose 5-phosphate synthase in a mouse model of UTI

Microbiology Spectrum(2024)10.1128/spectrum.03896-23

N/A

0.241DataRank · unranked

4 citations

Rachel Shapiro, Arindom Pal, David Bartee, Kevin DeLong, Davell M. Carter +5 more

Exploring the antimicrobial activity of pantothenamides against uropathogenic Escherichia coli

Microbiology Spectrum(2025)10.1128/spectrum.03069-24

N/A

0.104DataRank · unranked

1 citations

David J. Meyers, Arina Ranjit, James Paule, Erika Serrano-Diaz, Kimberly M. Bockley +4 more

Toward Understanding the Role of an Active Site Network in LThDP Stabilization on DXPS

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r5963

N/A

0DataRank · unranked

0 citations

Caren L. Freel Meyers, Eucolona Bonett

DXP Synthase Function in a Bacterial Metabolic Adaptation and Implications for Antibacterial Strategies

Antibiotics(2023)10.3390/antibiotics12040692

N/A

0DataRank · unranked

10 citations

Caren L. Freel Meyers, Eric C. Chen

Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations

Pharmaceutics(2023)10.3390/pharmaceutics15071835

N/A

0DataRank · unranked

6 citations

J. Hobson, Neill J. Liptrott, Edward Makarov, Amer Al‐khouja, Lee Tatham +12 more

Polymer–prodrug conjugates as candidates for degradable, long-acting implants, releasing the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine

Journal of Materials Chemistry B(2023)10.1039/d3tb02268d

N/A

0DataRank · unranked

1 citations

Faye Y. Hern, A. Shakil, Kartik Temburnikar, Pierre Chambon, Neill J. Liptrott +7 more

Potent Inhibition of E. coli DXP Synthase by a gem-Diaryl Bisubstrate Analog

ACS Infectious Diseases(2024)10.1021/acsinfecdis.3c00734

N/A

0DataRank · unranked

8 citations

Eucolona M. Toci, Percival Yang-Ting Chen, Catherine L. Drennan, Caren L. Freel Meyers, Lauren B. Coco

Disruption of an Active Site Network Leads to Activation of C2α-Lactylthiamin Diphosphate on the Antibacterial Target 1-Deoxy-d-xylulose-5-phosphate Synthase

Biochemistry(2024)10.1021/acs.biochem.3c00735

N/A

0DataRank · unranked

10 citations

Steven L. Austin, Ananya Majumdar, H. Lee Woodcock, Caren L. Freel Meyers, Eucolona M. Toci

Aldehyde‐based Activation of C2α‐lactylthiamin Diphosphate Decarboxylation on Bacterial 1‐deoxy‐d‐xylulose 5‐phosphate Synthase

ChemBioChem(2024)10.1002/cbic.202400558

N/A

0DataRank · unranked

5 citations

Ananya Majumdar, Caren L. Freel Meyers, Eucolona M. Toci

An activity-based probe for antimicrobial target DXP synthase, a thiamin diphosphate-dependent enzyme

Frontiers in Chemical Biology(2024)10.3389/fchbi.2024.1389620

N/A

0DataRank · unranked

3 citations

Caren L. Freel Meyers, Lauren B. Coco

Trihydroxybenzaldoximes are Redox Cycling Inhibitors of ThDP-Dependent DXP Synthase

ACS Chemical Biology(2025)10.1021/acschembio.5c00025

N/A

0DataRank · unranked

2 citations

Ananya Majumdar, Netzahualcóyotl Arroyo‐Currás, Caren L. Freel Meyers, Charles R. Nosal

Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants

Journal of Materials Chemistry B(2022)10.1039/d2tb00825d

N/A

0DataRank · unranked

8 citations

Faye Y. Hern, Chung Liu, Kartik Temburnikar, Pierre Chambon, Neill J. Liptrott +6 more

Structure–Activity Relationship Studies of Emtricitabine Prodrugs toward Long-Acting Antiretroviral Formulations

ACS Omega(2025)10.1021/acsomega.5c03319

N/A

0DataRank · unranked

0 citations

Stephanie Henriquez, J. Hobson, Jennifer A. White, Charles Flexner, Andrew Owen +3 more

Potential Impact of Long-Acting Products on the Control of Tuberculosis: Preclinical Advancements and Translational Tools in Preventive Treatment

Clinical Infectious Diseases(2022)10.1093/cid/ciac672

N/A

0DataRank · unranked

9 citations

Eric L. Nuermberger, Andrew Owen, Steve P. Rannard, Caren L. Freel Meyers, Susan Swindells +1 more